J.-M. Nabholtz
- Oncology top 5%
- Cancer Research top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Immunology
- Co-authors
- P. FumoleauM. NamerBenjamin WinogradG. CatimelM. SpielmannM. BontenbalPierfranco ContéJacques Bonneterre
- Topics
- Cancer Treatment and Pharmacology (14 papers)Breast Cancer Treatment Studies (12 papers)HER2/EGFR in Cancer Research (7 papers)
- Cited by
- OncologyCancer ResearchDermatology
- Partner nations
- CanadaFranceUnited States
In The Last Decade
J.-M. Nabholtz
23 papers receiving 711 citations
Peers
Comparison fields: 5 of 72
- Oncology 518
- Cancer Research 209
- Molecular Biology 187
- Radiology, Nuclear Medicine and Imaging 110
- Immunology 103
Countries citing papers authored by J.-M. Nabholtz
This map shows the geographic impact of J.-M. Nabholtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-M. Nabholtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-M. Nabholtz more than expected).
Fields of papers citing papers by J.-M. Nabholtz
This network shows the impact of papers produced by J.-M. Nabholtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-M. Nabholtz. The network helps show where J.-M. Nabholtz may publish in the future.
Co-authorship network of co-authors of J.-M. Nabholtz
This figure shows the co-authorship network connecting the top 25 collaborators of J.-M. Nabholtz. A scholar is included among the top collaborators of J.-M. Nabholtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-M. Nabholtz. J.-M. Nabholtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 49 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 13 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 51 | |
| 9 | 5 | |
| 10 | Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer. | 26 |
| 11 | An epidemiological review of red cell transfusions in cancer chemotherapy. | 15 |
| 12 | 1 | |
| 13 | 4 | |
| 14 | Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. | 31 |
| 15 | Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. | 24 |
| 16 | 5 | |
| 17 | 331 | |
| 18 | 7 | |
| 19 | 155 | |
| 20 | 1 |
About J.-M. Nabholtz
J.-M. Nabholtz is a scholar working on Cancer Research, Oncology and Hematology, having authored 24 papers that have together received 742 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (12 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Oncology (518 citations), Cancer Research (209 citations) and Dermatology (71 citations). J.-M. Nabholtz has collaborated with scholars based in Canada, France and United States. Frequent co-authors include P. Fumoleau, M. Namer, Benjamin Winograd, G. Catimel, M. Spielmann, M. Bontenbal, Pierfranco Conté, Jacques Bonneterre, Karen A. Gelmon and U. Klaassen. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.